A look at the shareholders of EC Healthcare (HKG:2138) can tell us which group is most powerful. With 62% stake, individual insiders possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).
It's interesting to note that insiders have been buying shares recently. Their expectations, however, were not satisfied, as the market cap dropped to HK$6.0b over the past week.
Let's take a closer look to see what the different types of shareholders can tell us about EC Healthcare.
View our latest analysis for EC Healthcare
SEHK:2138 Ownership Breakdown September 20th 2022
What Does The Institutional Ownership Tell Us About EC Healthcare?
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
We can see that EC Healthcare does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of EC Healthcare, (below). Of course, keep in mind that there are other factors to consider, too.
SEHK:2138 Earnings and Revenue Growth September 20th 2022
Hedge funds don't have many shares in EC Healthcare. Looking at our data, we can see that the largest shareholder is the CEO Chi Fai Tang with 61% of shares outstanding. This essentially means that they have significant control over the outcome or future of the company, which is why insider ownership is usually looked upon favourably by prospective buyers. For context, the second largest shareholder holds about 4.3% of the shares outstanding, followed by an ownership of 4.0% by the third-largest shareholder.
While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.
Insider Ownership Of EC Healthcare
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.
Our information suggests that insiders own more than half of EC Healthcare. This gives them effective control of the company. Given it has a market cap of HK$6.0b, that means they have HK$3.7b worth of shares. Most would argue this is a positive, showing strong alignment with shareholders. You can click here to see if those insiders have been buying or selling.
General Public Ownership
The general public, who are usually individual investors, hold a 22% stake in EC Healthcare. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.
Next Steps:
While it is well worth considering the different groups that own a company, there are other factors that are even more important.
I like to dive deeper into how a company has performed in the past. You can find historic revenue and earnings in this detailed graph.
If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
看看EC Healthcare(HKG:2138)的股東可以告訴我們哪個集團最有權勢。個人內部人士持有該公司62%的股份,擁有該公司的最大股份。也就是説,如果股價上漲,該集團將受益最大(如果股價下跌,該集團將損失最大)。
有趣的是,內部人士最近一直在買入股票。然而,隨着市值在過去一週跌至60億港元,他們的預期並未得到滿足。
讓我們仔細看看不同類型的股東能告訴我們關於EC Healthcare的什麼。
查看我們對EC Healthcare的最新分析
聯交所:2138擁有權分類2022年9月20日
關於EC Healthcare,機構所有權告訴了我們什麼?
許多機構以一個接近當地市場的指數來衡量它們的表現。因此,他們通常更關注那些被納入主要指數的公司。
我們可以看到,EC Healthcare確實有機構投資者;他們持有公司很大一部分股票。這意味着為這些機構工作的分析師已經看過了這隻股票,他們喜歡它。但就像其他人一樣,他們也可能錯了。如果兩個大型機構投資者試圖同時拋售一隻股票,股價大幅下跌的情況並不少見。因此,值得查看EC Healthcare過去的收益軌跡(見下圖)。當然,請記住,還有其他因素需要考慮。
聯交所:2138盈利及收入增長2022年9月20日
對衝基金在EC Healthcare的股份並不多。看看我們的數據,我們可以看到,第一大股東是擁有61%流通股的CEO遲輝堂。這本質上意味着他們對公司的結果或未來擁有重大控制權,這就是為什麼內部人所有權通常被潛在買家看好的原因。作為參考,第二大股東持有約4.3%的流通股,第三大股東持有4.0%的股份。
雖然研究一家公司的機構持股可以增加你的研究價值,但研究分析師的建議以更深入地瞭解一隻股票的預期表現也是一個很好的做法。有相當數量的分析師追蹤該股,因此瞭解他們對未來的總體看法可能是有用的。
EC Healthcare的內部人所有權
不同國家對內部人的定義可能略有不同,但董事會成員總是算數的。公司管理層管理企業,但首席執行官將向董事會負責,即使他或她是董事會成員。
我通常認為內部人持股是一件好事。然而,在某些情況下,這會讓其他股東更難讓董事會對決策負責。
我們的信息表明,內部人士擁有EC Healthcare一半以上的股份。這讓他們有效地控制了公司。鑑於其市值為60億港元,這意味着他們擁有價值37億港元的股票。大多數人會辯稱,這是積極的,表明了與股東的強烈一致。你可以點擊這裏,看看這些內部人士是一直在買入還是賣出。
一般公有制
公眾通常是個人投資者,他們持有EC Healthcare 22%的股份。儘管這種規模的所有權可能不足以影響有利於他們的政策決定,但他們仍然可以對公司政策產生集體影響。
接下來的步驟:
雖然考慮擁有一家公司的不同集團是很值得的,但還有其他更重要的因素。
我喜歡潛入更深的地方瞭解一家公司過去的表現。您可以在其中找到歷史上的收入和收益詳細圖表.
如果你像我一樣,你可能會想一想這家公司是會增長還是會萎縮。幸運的是,您可以查看這份顯示分析師對其未來預測的免費報告。
注:本文中的數字是使用過去12個月的數據計算的,指的是截至財務報表日期的最後一個月的12個月期間。這可能與全年的年度報告數字不一致。
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。